Jilin Province Huinan Changlong Bio-pharmacy Company Limited (JILIN CHANGLONG) issued a revised notice for its 2026 Annual General Meeting (AGM), dated 13 May 2026. The meeting remains scheduled for 10:00 a.m. on 9 June 2026 at the Economic Development Zone, Chaoyang Town, Huinan County, Jilin Province, PRC.

Key additions and agenda highlights are as follows:

1. New Ordinary Resolution • Ordinary Resolution 10 nominates Ms. Yang Yang as a supervisor for a three-year term ending at the 2029 AGM, with the Board authorised to set her remuneration.

2. Unchanged Ordinary Resolutions • Approval of the 2025 audited consolidated financial statements, Directors’ and Supervisory Committee reports. • Reappointment of Prism Hong Kong Limited as auditor for the financial year ending 31 December 2026. • Authorisation of 2026 remuneration packages for Directors and supervisors. • Re-election of five Directors and two supervisors for three-year terms. • Election of three additional executive Directors—Mr. Wang Wei, Ms. Chi Chun Hong and Ms. Li Ning—for three-year terms, with remuneration to be determined by the Board.

3. Special Resolution: General Mandate to Issue Shares The Board seeks authority to allot and issue up to 20 percent of the existing issued Domestic Shares and up to 20 percent of the existing issued H Shares, each with a nominal value of RMB 0.10, during the “Relevant Period.” The mandate excludes shares issued via rights issues, convertible securities, warrant exercises or scrip dividends and is conditional on approval from the China Securities Regulatory Commission. The Relevant Period runs until the earlier of: • the next AGM, • 12 months from the approval date, or • any earlier revocation or variation by shareholders in general meeting.

4. Proxy Arrangements Shareholders who have not returned the original proxy form should submit the revised proxy form enclosed with the notice no later than 24 hours before the AGM. Submission instructions differ for H-share and domestic shareholders, involving Computershare Hong Kong Investor Services Limited and the Company’s registered office respectively.

The revised notice does not alter the meeting’s date, venue or time, but formalises the additional supervisor nomination and clarifies proxy procedures while retaining all previously announced resolutions.